_logo_256_384.jpg){kind=logo}
Healthcare | August 04, 2021
Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai
It supports sequencing-based COVID 19 surveillance in India
It supports sequencing-based COVID 19 surveillance in India
Arch Pharma Labs has filed the application
Five seats reserved for Wards of COVID warriors in central MBBS admission
Complementary business models are the reason for the acquisition
India business is growing as per projections; whereas US business will bounce back soon.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
Subscribe To Our Newsletter & Stay Updated
